Navigation Links
Starpharma Develops New Gel (Vivagel) To Prevent HIV Transmission

The pharmaceutical company Starpharma saw an 8% increase in its share, following approval of Vivagel by the FDA, a new formulation, believed to prevent transmission of HIV. // The company even signed a $20 million (US) contract with the US National Institute of Allergy and Infectious Diseases, an integral part of the National Institute of Health.

'There are currently no approved products for the prevention of HIV infection. The FDA recognizes the potential of Vivagel to address this unmet medical need. Vivagel's new drug application will now receive priority review, which has a shorter assessment time. The early review is expected to shorten FDA's approval time significantly', said John Raff, Chief executive of Starpharma.

It is further hoped that the FDA’s initiative to accelerate the approval process would contribute to the development of the company, in the opinion of Jackie Fairley, Chief operating officer, Starpharma.

It was anticipated that the approval and commercial use of the drug would take about 13 months. With this green signal from the FDA, it could be materialized in less than 6 or 7 months according to official reports.

The product is primarily targeted at women, and would help them prevent contracting sexually transmitted diseases such as genital herpes, HIV and so on. The drug, a vaginal formulation has to be topically applied prior to intercourse and would function as a chemical barrier against various infections.

'Vivagel is not a treatment for HIV. The gel is used topically prior to sexual intercourse to prevent the women from becoming infected with HIV, genital herpes and other sexually transmitted diseases', said Dr Fairley.

AIDS is increasingly becoming a global burden, with nearly 40 million people afflicted with the disease worldwide. The number of genital herpes and AIDS/HIV in Australia is estimated to be 3.4 million and 15, 000 respectively. This is of great importan
'"/>




Page: 1 2

Related medicine news :

1. Kirin Develops a Cure for Bird Flu
2. Hungary Develops New Bird Flu Vaccine
3. Dutch chemical group Akzo Nobel Develops A New Bird Flu Vaccine
4. Samsung Develops Device to Measure Body Fat
5. India Develops Test for Diagnosis of Deadly Livestock Disease
6. Mouth Cancer Develops In Two Different Ways
7. John Hopkins Develops An Online Tool To Help In Research Of Certain Rare Diseases
8. Researcher Develops Sensor to Detect E.coli
9. Australian Firm Develops Low Glycaemic Sugar to Prevent Diabetes
10. US Company Develops Better Weight Reduction Pill
11. Rhode Island Biotechnology Company Develops Tularemia Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Starpharma Develops New Gel Vivagel Prevent HIV Transmission

(Date:7/22/2014)... 2014 A new and technologically unique ... with results that are surprising even the most skeptical ... skin with radio frequency, ThermiTight has been dubbed “InjectableRF” ... the skin to “inject” heat to the tissues which ... single treatment solution for skin laxity produces results in ...
(Date:7/21/2014)... On Monday, September 22, 2014 Push to Walk will ... Solutions at The Knoll West Country Club, Knoll & Greenbank ... at 11 a.m. The price of $225 includes all ... $250 after September 7th. Non-golfers and guests are welcome ... dinner will include a special silent and live auction in ...
(Date:7/21/2014)... PowerObjects, a professional services firm ... add-ons for Microsoft Dynamics CRM, has joined the ... group of the most strategic Microsoft Dynamics partners ... rank them in the highest echelon of the ... the Microsoft Dynamics Inner Circle have performed to ...
(Date:7/21/2014)... It,s human nature to hate losing. , Unfortunately, ... potentially abandoning a solid strategy and thus increasing your ... one conclusion of a Brigham Young University study published ... The finding is based on an analysis of two ... researchers focused on whether coaches adjusted their personnel following ...
(Date:7/21/2014)... Center for Public Affairs Research has released the results ... what it means to be a quality health care ... the Robert Wood Johnson Foundation, sheds new light on ... care and doctors, as well as the information they ... survey produces new and actionable data during a crucial ...
Breaking Medicine News(10 mins):Health News:New Minimally Invasive Procedure, ThermiTight, “Injects” Radio Frequency to Treat Skin Laxity 2Health News:7th Annual Push to Walk Golf Outing to Be Held September 22nd 2Health News:PowerObjects Joins the 2014 Microsoft Dynamics Inner Circle 2Health News:'Moral victories' might spare you from losing again 2Health News:National survey from AP-NORC examines perceptions of health care provider quality 2
... of therapeutic agents that interferes with the ability of ... The results of the new study will be presented ... Meeting in San Francisco. , The cell-based study ... compounds are likely to be effective against breast cancers ...
... scientists work collaboratively, barriers of religion and ethnicity ... science to improve the lives of citizens worldwide. ... Gluck, professor of neuroscience at Rutgers University in ... after successfully organizing an international conference co-hosted by ...
... 16 Pittsburgh-based Foundation,Radiology Group (FRG) and Cherry ... which will make FRG the exclusive provider of,diagnostic ... Kishor E. Joshi, M.D., president of Cherry Tree ... Foundation Radiology Group. We expect,this partnership will enhance ...
... Association, a,regional non-profit established to foster relationships and ... announced today,the election of five new officers and ... New officers who were elected to serve a ... president, Aon Consulting; Past President - Thomas,Hoffman, partner, ...
... studies indicate that oral use of RU-486,s companion drug misoprostol ... , The off-label use of a drug given with RU-486 ... of rare, fatal infections seen in women taking the drugs ... , The drug misoprostol is FDA-approved to be taken ...
... & Lymphoma Society,s Light The Night(R) Walk Offers Relief at ... the ... prices may be,putting the brakes on Americans, summer travel plans, but The ... cards,and a chance to win an all-expense paid vacation., Light The ...
Cached Medicine News:Health News:Future hope for patients with breast cancers resistant to tamoxifen 2Health News:US-Israeli-Palestinian collaboration to advance Alzheimer's disease research 2Health News:Foundation Radiology Group and Cherry Tree Medical Associates Sign Multi-Year Contract for Diagnostic Services 2Health News:SouthWest Benefits Association Elects New Board of Directors 2Health News:Abortion drug's off-label use may have led to deaths 2Health News:Abortion drug's off-label use may have led to deaths 3Health News:Get Free Gas and Help Save a Life 2
(Date:7/21/2014)... July 21, 2014 Galmed Pharmaceuticals Ltd. (Nasdaq: ... focused on the development and commercialization of a once-daily, ... cholesterol gallstones, announced today that it will host a ... to discuss results for the period ended June 30, ... with respect to its clinical program for aramchol. ...
(Date:7/21/2014)... Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... treatments for cancer and its associated pain, today announced ... development of a small molecule inhibitor targeting the important ... protein has also been recognized as an important determinant ... as a dominant factor in most human cancers and ...
(Date:7/21/2014)... MARYVILLE, Ill. , July 21, 2014 /PRNewswire-iReach/ ... that Dr. Ryan Diederich has been ... on Membership and Advocacy for 2014-2015. This council ... member resources, services and benefits. The ... that represents and unifies its physician members as ...
Breaking Medicine Technology:Galmed Pharmaceuticals Second Quarter 2014 Conference Call and Webcast Scheduled for Friday, July 25, 2014 2Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 2Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 3Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 4
... Dec. 21, 2011  VIVUS, Inc. (NASDAQ: VVUS ... retrospective study of medical claims data on oral ... utero .  The study, known as FORTRESS for ... mother-infant dyads exposed to topiramate either alone (monotherapy) ...
... Dec. 21, 2011 Despite the numerous medical advances ... the United States is still higher than most European ... the growing rate of pre-term births, researchers are committed ... Northwestern Medicine ® researchers are examining ...
Cached Medicine Technology:VIVUS Reports Topline Findings From FORTRESS 2VIVUS Reports Topline Findings From FORTRESS 3VIVUS Reports Topline Findings From FORTRESS 4VIVUS Reports Topline Findings From FORTRESS 5VIVUS Reports Topline Findings From FORTRESS 6Northwestern Researchers Trial New Device that May Support Improved Newborn Health 2Northwestern Researchers Trial New Device that May Support Improved Newborn Health 3Northwestern Researchers Trial New Device that May Support Improved Newborn Health 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: